FDA Bioequivalence Standards for NTI Drugs: Special Requirements Explained
The FDA enforces stricter bioequivalence standards for NTI drugs to ensure safety, requiring tighter limits (90-111%) and replicate studies. These rules apply to critical medications like warfarin, phenytoin, and tacrolimus, where small dosage differences can cause serious harm.